Literature DB >> 2040363

Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells.

C Bolden1, B Cusack, E Richelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2040363     DOI： 10.1016/0014-2999(91)90096-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  10 in total

Review 1.  Clinical profile of clozapine: adverse reactions and agranulocytosis.

Authors:  J A Lieberman; A Z Safferman
Journal:  Psychiatr Q       Date:  1992

2.  A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter.

Authors:  I T Bognar; U Altes; C Beinhauer; I Kessler; H Fuder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

Review 3.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors.

Authors:  M Kathmann; E Schlicker; M Göthert
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

5.  The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.

Authors:  C Johansson; D M Jackson; L Svensson
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

6.  The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine.

Authors:  D M Weiner; H Y Meltzer; I Veinbergs; E M Donohue; T A Spalding; T T Smith; N Mohell; S C Harvey; J Lameh; N Nash; K E Vanover; R Olsson; K Jayathilake; M Lee; A I Levey; U Hacksell; E S Burstein; R E Davis; M R Brann
Journal:  Psychopharmacology (Berl)       Date:  2004-07-16       Impact factor: 4.530

7.  Selectivity of oxomemazine for the M1 muscarinic receptors.

Authors:  S W Lee; C W Woo; J G Kim
Journal:  Arch Pharm Res       Date:  1994-12       Impact factor: 4.946

8.  Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats.

Authors:  P Protais; M Windsor; E Mocaër; E Comoy
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

Review 9.  Targeting muscarinic receptors to treat schizophrenia.

Authors:  Daniel J Foster; Zoey K Bryant; P Jeffrey Conn
Journal:  Behav Brain Res       Date:  2021-02-26       Impact factor: 3.332

10.  Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report.

Authors:  Soohyun Joe; Jangho Park; Jongseok Lim; Choongman Park; Joonho Ahn
Journal:  BMC Psychiatry       Date:  2015-10-19       Impact factor: 3.630
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.